Pregnancy outcomes in oocyte donation recipients: Vaginal gel versus intramuscular injection progesterone replacement

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 3, 2012, Pages 237-242

  Berger, Brian M ^a   Phillips, James A ^a,b  

^a BOSTON IVF   (United States)

^b Sage Statistical Solutions Inc   (United States)

Author keywords

Crinone 8 (progesterone gel); Luteal phase; Oocyte donation; Progesterone replacement

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; AGENTS USED INTRAVAGINALLY; DRUG DERIVATIVE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; OOCYTE DONATION; OOCYTE RETRIEVAL; PREGNANCY OUTCOME; PREGNANCY TEST; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; BLOOD; DELAYED RELEASE FORMULATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PREGNANCY; PREGNANCY RATE;

ADULT; CHORIONIC GONADOTROPIN; DELAYED-ACTION PREPARATIONS; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE REPLACEMENT THERAPY; HUMANS; INFERTILITY; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84863202873     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-011-9691-9     Document Type: Article

References (30)

1. Dey SK, Johnson DC. Embryo-uterine interaction in implantation. Life Sci. 1980;27:2381-4. (Pubitemid 11169709)
2. Dey SK, Davis DL, Hersey RM,Weisz J, Johnson DC, Pakrasi PL. Physiological aspects of blastocyst uterine interaction. J Biosci. 1984;6 SUPPL. 2:23-31.
3. Emiliani S, Delbaere A, Devreker F, Englert Y. Embryo-maternal interactive factors regulating the implantation process: implications in assisted reproduction. Reprod Biomed. 2005;Online 10:527-40. (Pubitemid 40485017)
4. de Ziegler D, Fanchin R, Massonneau M, Bergeron C, Frydman R, Bouchard P. Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation. Ann NY Acad Sci. 1994;734:209-20.
5. Punyadeera C, Verbost P, Groothuis P. Oestrogen and progestin responses in human endometrium. J Steroid Biochem Mol Biol. 2003;84:393-410. (Pubitemid 36555763)
6. Friedler S, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotropin-releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod. 1999;14:1944-8. (Pubitemid 29381223)
7. Licciardi FL, Kwiatkowski A, Noyes NL, Berkley AS, Krey LL, Grifo JA. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril. 1999;71:614-8. (Pubitemid 29149408)
8. Bulletti C, de Ziegler D, Flamigni C, Giacomucci E, Polli V, Bolelli G, et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod. 1997;12:1073-9. (Pubitemid 27271774)
9. Ciccinelli E, de Ziegler D, Bulletti C, Matteo MG, Schronauer LM, Galantino P. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95:403-6. (Pubitemid 30100507)
10. Levine H. Luteal support from the vaginal progesterone (P) gel Crinone 8%: preliminary results of multicenter trial show higher pregnancy rates than historical controls. J Soc Gynecol Investig. 2000;7 SUPPL. 571:203A.
11. Schoolcraft WB, Hesla JS, Gee MJ. Experience with progesterone gel for luteal support in a highly successful IVF programme. Hum Reprod. 2000;15:1284-8. (Pubitemid 30335951)
12. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone SUPPL.ementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril. 2008;89:485-7. (Pubitemid 351215406)
13. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril. 2007;87:83-7.
14. Anserini M, Costa M, Remorgida V, Sarli R, Guglielminetti E, Ragni R. Luteal phase support in assisted reproduction cycles using either vaginal (Crinone 8) or systemic (Prontogest) progesterone: results of a prospective, randomized study. Minerva Ginecol. 2001;53:297-301. (Pubitemid 32895931)
15. Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril. 1999;72:823-9. (Pubitemid 29505445)
16. Ottoson UB, Carlstrom K, Damber JE, von Schoultz B. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br J Obstet Gynaecol. 1984;91:1111-9. (Pubitemid 15210943)
17. Stanczyk FZ. Pharmacokinetics of progesterone administered by the oral and parenteral routes. J Reprod Med. 1999;44:141-7. (Pubitemid 29116019)
18. Gibbons WE, Toner JP, Hammacher P, Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril. 1998;69:96-101. (Pubitemid 28073000)
19. Williams SC, Donahue J, Muasher SJ. Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates [Abstract P-363]. Fertil Steril. 2000;74 SUPPL. 1:S209.
20. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature. 1984;307:174-5. (Pubitemid 14132906)
21. Crinone® 4% and Crinone® 8% (progesterone gel) [prescribing information], Livingston, NJ: Columbia Laboratories, Inc. 2009.
22. Witmyer J, Wang S, Alper M, Powers R. HIP embryos: effective criteria for high pregnancy rates with low high order multiples. Fertil Steril. 2003;80:S139-40.
23. Greenblatt DJ, Allen MD. Intramuscular injection site complications. JAMA. 1978;49:536.
24. Al-Shawaf T, Zosmer A, Dirnfeld M, Grudzinkas G. Safety of drugs used in assisted reproduction techniques. Drug Saf. 2005;28:513-28. (Pubitemid 41003056)
25. Penzias A, Alper M. Luteal support with vaginal micronized progesterone gel in assisted reproduction. Reprod Biomed. 2003; Online 6:187-295.
26. Phipps WR, Benson CB, McShane PM. Severe thigh myositis following intramuscular progesterone injection in an in vitro fertilization patient. Fertil Steril. 1988;49:536-7. (Pubitemid 18064015)
27. Phy J. Hypersensitivity to progesterone-in-oil after in vitro fertilization and embryo transfer. Fertil Steril. 2003;80:1272-5. (Pubitemid 37377764)
28. Kline DG, Kim D, Midha R, Harsh C, Tiel R. Management and results of sciatic nerve injuries: a 24-year experience. J Neurosurg. 1998;89:13-23. (Pubitemid 28285917)
29. Bouckaert Y, Robert F, Englert Y, De Backer D, De Vuyst P, Delbaere A. Acute eosinophilic pneumonia associated with intramuscular injection of progesterone as luteal phase support after IVF: case report. Hum Reprod. 2004;19:1806-10. (Pubitemid 39144627)
30. Veysman B, Vlahos I, Oshva L. Pneumonitis and eosinophilia after in vitro fertilization. Ann Emerg Med. 2006;47:472-5.